Keywords: pfizer, maraviroc, impresses, hiv, trials, usa-based, drug

Pfizer's maraviroc impresses in HIV trials

Article | 12 March 2007

Print This

USA-based drug giant Pfizer says that 24-week data from a trial of its antiviral maraviroc indicate that nearly double the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in